(Q38149953)

29 August 2017

title

Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia (English)

1 reference

29 August 2017

0 references

cognitive dysfunction

1 reference

Herbert Y Meltzer

1

1 reference

29 August 2017

Lakshmi Rajagopal

2

1 reference

29 August 2017

Mei Huang

3

1 reference

29 August 2017

Yoshihiro Oyamada

4

1 reference

29 August 2017

Sunoh Kwon

5

1 reference

29 August 2017

Masakuni Horiguchi

6

1 reference

29 August 2017

publication date

1 November 2013

1 reference

The International Journal of Neuropsychopharmacology

29 August 2017

published in

1 reference

29 August 2017

volume

16

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

2181-2194

1 reference

Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

A novel delayed non-match to sample object recognition task that allows simultaneous in vivo microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Treating impaired cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The 5-HT7 receptor and disorders of the nervous system: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Animal model for schizophrenia that reflects gene-environment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The declarative/procedural model of lexicon and grammar

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Acetylcholine release from the frontal cortex during exploratory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neurocognitive performance and functional disability in the psychosis prodrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Periadolescent exposure to the NMDA receptor antagonist MK-801 impairs the functional maturation of local GABAergic circuits in the adult prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Serotonin 5-HT(7) receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Managing the prodrome of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Synaptic changes in the brain of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Ketamine alters the neurogenesis of rat cortical neural stem progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

5-HT system and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

General and specific cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: comparison with reference dose risperidone, 6mg/day

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Declarative memory deficits and schizophrenia: problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Hippocampal neurotransmitter efflux during one-trial novel object recognition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Tonic excitation or inhibition is set by GABA(A) conductance in hippocampal interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

5-HT(6) receptor and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

[3H]WAYâ 100635 for 5â HT1A receptor autoradiography in human brain: a comparison with [3H]8â OHâ DPAT and demonstration of increased binding in the frontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Update on typical and atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Role of serotonin in memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Evaluation of a neurodevelopmental model of schizophrenia--early postnatal PCP treatment in attentional set-shifting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Dopamine receptor polymorphisms and drug response in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The 5-HT(7) receptor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Models of neurodevelopmental abnormalities in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

The neurodevelopmental hypothesis of schizophrenia: convergent clues from epidemiology and neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neuropsychological risk indicators for schizophrenia: a review of family studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Attention and higher cortical functions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Cognitive impairment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Effects of neonatal repeated MK-801 treatment on delayed nonmatching-to-position responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Effects of low-dose D-serine on recognition and working memory in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Pretreatment predictors of cognitive deficits in early psychosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Effects of repeated dizocilpine treatment on adult rat behavior after neonatal lesions of the entorhinal cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Effects of repeated phencyclidine treatment on serotonin transporter in rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Neurocognition in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Protection with phencyclidine against inactivation of 5-HT2 receptors by sulfhydryl-modifying reagents

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Increase of extracellular dopamine in primate prefrontal cortex during a working memory task

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000928

7 January 2021

10.1017/S1461145713000928

Identifiers

DOI

1 reference

29 August 2017

1 reference